Stay updated with breaking news from Davidc Marek. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) have been given an average recommendation of “Hold” by the seven analysts that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and two have given a buy recommendation to the […]
Myovant Sciences (NYSE:MYOV – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women’s health diseases and other endocrine-related disorders, including […]
Equities analysts predict that Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) will announce earnings of ($0.54) per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Myovant Sciences’ earnings, with the highest EPS estimate coming in at ($0.40) and the lowest estimate coming in at ($0.63). Myovant […]